The goal of ACTIV is to develop a research strategy for prioritizing and speeding development of the most promising COVID-19 vaccines and treatments.


The Vaccines Working Group is focused on:

  • Harmonizing efficacy trials to enable analysis of correlates of protection across vaccines
  • Creating a collaborative framework to share insights into natural immunity and vaccine candidate-induced immune response


Prospects for a safe COVID-19 vaccine